The Mounjaro Cost Rise Explained: Private Pricing After September 2025

Free clinical consultation included — no separate assessment fee to pay upfront
Prescription written by a GPhC-registered Independent Prescriber, reviewed personally the same day
Free next-working-day DPD delivery once approved, in plain unbranded packaging
Priority aftercare available seven days a week, with no subscription or auto-renewal

Mounjaro's UK private price rose sharply from September 2025, after Eli Lilly revised its list pricing for tirzepatide. The highest-dose pen moved from around £122 to around £330, and every strength in between shifted proportionally — making this the most significant single price change in the UK weight-management market since Mounjaro launched. That jump has understandably prompted questions about what's included, what's fair, and whether private treatment is still a realistic option. These are prescription-only medicines that can only be dispensed following a clinical assessment by a registered prescriber, so the full picture is more than just a list price. Here is what actually happened, what private providers' prices typically cover (and what they often don't), and how to think about value when you're comparing a medication that sits in the fridge door next to everything else you rely on daily.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How the September 2025 Price Rise Reshaped the Private Market, and What to Look For

Step 1: Understanding what Eli Lilly actually changed

Before September 2025, the UK private market had settled into a relatively narrow band of pricing for Mounjaro. Eli Lilly's list price for a four-week pen at the highest strength sat at roughly £122, and private providers built their offers around that baseline. If you want to understand what drove the change, our page on why Mounjaro price rises happened and what Lilly's decision involved sets out the detail clearly. The revised pricing that took effect from 1 September 2025 pushed that same pen to approximately £330, as widely reported at the time of the Lilly UK announcement. Lower doses moved too, though the percentage increases varied by strength.

What matters practically is that the list price is not the retail price. Private pharmacies and clinics set their own fees, which means the market price after September 2025 ranges roughly between £149 and £375 per month depending on dose and provider, according to widely reported figures. Those figures are useful context, but they tell you nothing about what each price actually delivers alongside the medicine itself. That is where the comparison gets more complicated, and more important. More background on the timeline of the Mounjaro price rise is available if you want the history in full.

Step 2: What headline prices often leave out

A quoted monthly price can look straightforwardly comparable until you read what it includes. Some providers charge a separate consultation fee before you can access the medicine. Others add a prescription charge on top. Delivery (particularly tracked next-day courier delivery for a temperature-sensitive injectable) may be an additional line item. Dose-review support, the clinical oversight that checks whether your current strength is still appropriate, is sometimes bundled in and sometimes billed separately or simply absent.

Aftercare matters more than it sounds. Tirzepatide is a Black Triangle medicine subject to additional MHRA monitoring, and questions about side effects, dose progression and how the treatment fits around other medications do come up, a question our prescribers hear most weeks. A fuller breakdown of what Mounjaro costs in the UK covers the components in detail. The point here is that a £20 difference in headline price can dissolve entirely once you account for what isn't included in the cheaper quote.

Step 3: Where nume sits, and why we're transparent about it

Cheapest isn't a race we entered. One transparent price covers everything: the consultation, the prescription written by a GPhC-registered Independent Prescriber who personally reviews your case the same day, the medicine, and free next-working-day tracked DPD delivery, no add-ons, no repeat fees, no subscription that renews automatically. The current treatment pricing is shown on our weight-loss treatments page. We don't print per-pen prices here because the right starting point is a clinical conversation, not a price comparison, and because what you'll be prescribed depends on your health history, not a menu.

Every repeat order at nume is clinically re-reviewed before dispatch. That is not a marketing claim; it is a requirement. Our clinical team reviews the evidence for each dose increase rather than auto-approving progression. If you want to understand the service itself, our about page covers the pharmacy registration and how the team works. For questions that come up between orders, our FAQs are a useful first stop, and our support team is available seven days a week.

Step 4: Why 'cheapest' is the wrong test for a prescription medicine

The MHRA has documented the risks of buying weight-loss injectables from unverified sellers directly. Large seizures of fake pens have occurred, some containing insulin rather than tirzepatide, a potentially life-threatening substitution. The red flags are consistent: offers made without a clinical assessment, prices far below the market range, and discount codes from sellers who can't be verified on the GPhC register.

Any legitimate UK pharmacy dispensing Mounjaro can be verified at the GPhC pharmacy register, our premises number is 9012878. A small saving on the headline price is not the measure that keeps you safe. The measure that matters is whether a registered prescriber has assessed your suitability, whether the medicine comes from a licensed UK supply chain, and whether there is qualified clinical support if something doesn't feel right. Concerns about affordability are real and understandable, and if you want advance notice of what Mounjaro prices to rise further could mean for your treatment costs, that page covers the outlook in full. But the answer to a higher price is not a supplier who skips the clinical step.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions